Rosacea

New England Journal of Medicine

Volumn 352, Issue 8, 2005, Pages

  Powell, Frank C ^a  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AMYL NITRATE; ANTACID AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; AZELAIC ACID; AZITHROMYCIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLONIDINE; CORTICOSTEROID; DOXYCYCLINE; ERYTHROMYCIN; ISOTRETINOIN; METRONIDAZOLE; MINERAL; MINOCYCLINE; NADOLOL; NICOTINIC AGENT; OPIATE; OXYTETRACYCLINE; PHENOBARBITAL; RETINOIC ACID; SPIRONOLACTONE; SULFACETAMIDE; TETRACYCLINE; VASODILATOR AGENT; ANTIINFECTIVE AGENT; SUNSCREEN;

ADULT; BURNING SENSATION; CASE REPORT; CLINICAL FEATURE; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; ENAMEL HYPOPLASIA; ERYTHEMA; FACE; FEMALE; FLUSHING; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HYPERPIGMENTATION; INTRACRANIAL HYPERTENSION; LEUKOPENIA; NEUROLOGIC DISEASE; PAPULE; PERIORAL DERMATITIS; PERIPHERAL NEUROPATHY; PHOTOSENSITIVITY DISORDER; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PRURITUS; PUSTULE; REVIEW; ROSACEA; SEIZURE; SIDE EFFECT; TELANGIECTASIA; TOOTH COLOR; XEROSIS; CLASSIFICATION; EYE DISEASE; INTRADERMAL DRUG ADMINISTRATION; MALE; MIDDLE AGED; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ANTI-BACTERIAL AGENTS; EYE DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; RHINOPHYMA; ROSACEA; SUNSCREENING AGENTS;

EID: 13844306331     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMcp042829     Document Type: Review

References (52)

1. Wilkin JK. Rosacea. Int J Dermatol 1983;22:393-400.
2. Starr PA. Oculocutaneous aspects of rosacea. Proc R Soc Med 1969;62:9-11.
3. Lonne-Rahm SB, Fischer T, Berg M. Stinging and rosacea. Acta Derm Venereol 1999;79:460-1.
4. Crawford GH, Pelle MT, James WD. Rosacea: I. Etiology, pathogenesis, and sub-type classification. J Am Acad Dermatol 2004;51:327-41.
5. Helm KF, Menz J, Gibson LE, Dicken CH. A clinical and histopathologic study of granulomatous rosacea. J Am Acad Dermatol 1991;25:1038-43.
6. Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol 2002;46:584-7.
7. Wilkin J, Dahl M, Detmar M, et al. Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol 2004;50:907-12.
8. Sobye P. Aetiology and pathogenesis of rosacea. Acta Derm Venereol 1950;30:137-58.
9. Kligman AM. A personal critique on the state of knowledge of rosacea. Dermatology 2004;208:191-7.
10. Ramelet AA. Rosacea: a reaction pattern associated with ocular lesions and migraine? Arch Dermatol 1994;130:1448.
11. Diaz C, O'Callaghan C, Khan A, IIchyshyn A. Rosacea: a cutaneous marker of Helicobacter pylori infection? Results of a pilot study. Acta Derm Venereol 2003;83:282-6.
12. Litt JZ. Steroid-induced rosacea. Am Fam Physician 1993;48:67-71.
13. Antille C, Saurat JH, Lubbe J. Induction of rosaceiform dermatitis during treatment of facial inflammatory dermatoses with tacrolimus ointment. Arch Dermatol 2004;140:457-60.
14. Lomholt G. Prevalence of skin diseases in a population - a census study from the Faroe Islands. Dan Med Bull 1964;11:1-7.
15. Berg M, Liden S. An epidemiological study of rosacea. Acta Derm Venereol 1989;69:419-23.
16. Plewig G, Kligman AM. Acne and rosacea. 2nd ed. Berlin: Springer-Verlag, 1993.
17. Rebora A. The red face: rosacea. Clin Dermatol 1993;11:225-34.
18. Powell FC. The histopathology of rosacea: 'where's the beef? Dermatology 2004;209:173-4.
19. Sugarman JH, Fleischer AB Jr, Feldman SR, Off-label prescribing in the treatment of dermatologic disease. J Am Acad Dermatol 2002;47:217-23.
20. Wilkin JK. Rosacea: pathophysiology and treatment. Arch Dermatol 1994;130:359-62.
21. Greaves MW, Burova EP. Flushing: causes, investigation and clinical consequences. J Eur Acad Dermatol Venereol 1997;8:91-100.
22. Wilkin JK. Effect of nadolol on flushing reactions in rosacea. J Am Acad Dermatol 1989;20:202-5.
23. Drott C, Claes G, Olsson-Rex L, Dalman P, Fahlen T, Gothberg G. Successful treatment of facial blushing by endoscopic transthoracic sympathicotomy. Br J Dermatol 1998;138:639-43.
24. Tan R, Tope WD. Pulsed dye laser treatment of rosacea improves erythema, symptomology, and quality of life. J Am Acad Dermatol 2004;51:592-9.
25. Del Rosso JQ. Medical treatment of rosacea with emphasis on topical therapies. Expert Opin Pharmacother 2004;5:5-13.
26. van Zuuren EJ, Graber MA, Hollis S, Chaudhry M, Gupta AK. Interventions for rosacea. Cochrane Database Syst Rev 2004;1:CD003262.
27. Thiboutot D, Thieroff-Ekerdt R, Graupe K. Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: results from two vehicle-controlled, randomized phase III studies. J Am Acad Dermatol 2003;48:836-45.
28. Elewski BE, Fleischer AB Jr, Pariser DM. A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the treatment of papulopustular rosacea: results of a randomized trial. Arch Dermatol 2003;139:1444-50.
29. Sauder D, Miller R, Gratton D, et al. The treatment of rosacea: the safety and efficacy of sodium sulfacetamide 10% and sulfur 5% lotion (Novacet) is demonstrated in a double-blind study. J Dermatol Treat 1997;8:79-85.
30. Lebwohl M, Medansky RS, Russo CL, Plott RT. The comparative efficacy of sodium sulfacetamide 10% sulphur 5% (Sulfacet R) lotion and metronidazole 0.75% gel (Metrogel) in the treatment of rosacea. J Geriatr Dermatol 1995;3(6):183-5.
31. Mills OH Jr, Kligman AM. Topically applied erythromycin in rosacea. Arch Dermatol 1976;112:553-4.
32. Pye RI, Burton JL. Treatment of rosacea by metronidazole. Lancet 1976;1:1211-2.
33. Saihan EM, Burton JL. A double-blind trial of metronidazole versus oxytetracycline therapy for rosacea. Br J Dermatol 1980;102:443-5.
34. Jansen T, Plewig G. Rosacea: classification and treatment. J R Soc Med 1997;90:144-50.
35. Fernandez-Obregon A. Oral use of azithromycin for the treatment of acne rosacea. Arch Dermatol 2004;140:489-90.
36. Erlt GA, Levine N, Kligman AM. A comparison of the efficacy of topical tretinoin and low-dose oral isotretinoin in rosacea. Arch Dermatol 1994;130:319-24.
37. Pelle MT, Crawford GH, James WD. Rosacea: II. Therapy. J Am Acad Dermatol 2004;51:499-512.
38. Powell FC. Rosacea. In: Katsambas AD, Lotti TM, eds, European handbook of dermatological treatments. 2nd ed. Berlin: Springer-Verlag, 2003.
39. Sobye P. Treatment of rosacea by massage. Acta Derm Venereol 1951;31:174-83.
40. Knight AG, Vickers CFH. A follow-up of tetracycline-treated rosacea: with special reference to rosacea keratitis. Br J Dermatol 1975;93:577-80.
41. Dahl MV, Katz HI, Krueger GG, et al. Topical metronidazole maintains remissions of rosacea. Arch Dermatol 1998;134:679-83.
42. Wilkin JK. Use of topical products for maintaining remission in rosacea. Arch Dermatol 1999;135:79-80.
43. Roberts JO, Ward CM. Rhinophyma. J R Soc Med 1985;78:678-81.
44. Aloi F, Tomasini C, Soro E, Pippione M. The clinicopathologic spectrum of rhinophyma. J Am Acad Dermatol 2000;42:468-72.
45. Murphy A, O'Keane JC, Blayney A, Powell FC. Cutaneous presentation of nasal lymphoma: a report of two cases. J Am Acad Dermatol 1998;38:310-3.
46. el-Azhary RA, Roenigk RK, Wang TD. Spectrum of results after treatment of rhinophyma with the carbon dioxide laser. Mayo Clin Proc 1991;66:899-905.
47. Kligman AM. Ocular rosacea: current concepts and therapy. Arch Dermatol 1997;133:89-90.
48. Gudmundsen KJ, O'Donnell BF, Powell FC. Schirmer testing for dry eyes in patients with rosacea. J Am Acad Dermatol 1992;26:211-4.
49. Bartholomew RS, Reid BJ, Cheesbrough MJ, Macdonald M, Galloway NR, Oxytetracycline in the treatment of ocular rosacea: a double-blind trial. Br J Ophthalmol 1982;66:386-8.
50. Quarterman MJ, Johnson DW, Abele DC, Lesher JL Jr, Hull DS, Davis LS. Ocular rosacea: signs, symptoms, and tear studies before and after treatment with doxycycline. Arch Dermatol 1997;133:49-54.
51. Powell FC. What's going on in rosacea? J Eur Acad Dermatol Venereol 2000;14:351-2.
52. Ernst E. The use of complementary therapies by dermatological patients: a systematic review. Br J Dermatol 2000;142:857-61.